期刊文献+

子宫内膜异位症中血管内皮生长因子、血管生成素-2与微血管密度的表达及临床意义 被引量:15

Expression and clinical significance of vascular endothelial growth factor,angiogenin-2 and microvessel density in endometriosis
原文传递
导出
摘要 目的:探讨卵巢子宫内膜异位症(EMs)患者在位、异位内膜组织及正常子宫内膜组织中血管内皮生长因子(VEGF)及血管生成素-2(Ang-2)、微血管密度(MVD)的表达情况及其相关性。方法:选取深圳龙岗中心医院2012年9月~12月间收集的EMs手术患者在位内膜和异位内膜组织71例为研究对象,同时选取66例正常子宫内膜组织为对照组,应用免疫组化二步法联合检测Ang-2、VEGF、CD 105的表达。结果:EMs患者在位、异位内膜组织、正常子宫内膜组织中VEGF及Ang-2、CD 105的阳性表达与对照组差异有统计学意义(P<0.05);VEGF、Ang-2、CD 105阳性表达在异位、在位内膜及正常内膜组织中及各增生期与分泌期比较差异有统计学意义(P<0.05);VEGF、Ang-2、CD 105阳性表达在异位、在位内膜中均有相关性(P<0.05)。结论:Ang-2、VEGF、CD 105过度表达可能与EMs的发生和发展密切相关,并起协同作用。 Objective: To investigate the expression of vascular endothelial growth factor (VEGF) , angiogenin (Ang -2) and mierovascular density (MVD) in eutopic and ectopic endometrium of ovarian endometriosis (EMs) patients and normal endometrial tissue and their correlation. Methods: From September 2012 - December 2012, EMs patients in Longgang Central Hospital were selected, 71 cases of eutopic and eetopic endometrial tissue were collected as subjects, while 66 cases of normal endometrial tissue were selected as con- trois, expression of Ang - 2, VEGF and CD 105 were detected by two - step immunohistochemieal method. Results: The positive expres- sion of VEGF, Ang- 2 and CDI05 in eutopic, ectopic and normal endometrium of EMs patients was statistically different from the control group (P 〈 0. 05) ; the positive expression of VEGF, Ang- 2, CDI05 in these tissues was statistically significant in different hyperplasia period and secretory phase (P 〈0.05) ; the positive expression of VEGF, Ang-2, CD105 in ectopic and eutopie endometrial tissue had correlation (P 〈 0.05 ) . Conclusion: Ang- 2, VEGF, CD105 excessive expression may be closely related to occurrence and development of EMs, and play a synergistic role.
作者 凌艳 刘阳
出处 《中国妇幼保健》 CAS 北大核心 2014年第2期191-193,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献5

二级参考文献23

共引文献30

同被引文献143

  • 1苑春莉,王医术,盛辉,李荷莲,马宁,王筱璐,曾晓娟.胰岛素样生长因子Ⅰ及其受体在子宫内膜异位症中的表达[J].吉林大学学报(医学版),2007,33(3):567-569. 被引量:5
  • 2程明军,徐丛剑.子宫内膜异位症的发病机制理论及学说[J].中国实用妇科与产科杂志,2007,23(7):561-562. 被引量:31
  • 3乐杰.妇产科学.第五版.北京:人民卫生出版社,2002,135-139. 被引量:4
  • 4石一复,郝敏.子宫内膜异位症诊疗新进展[M].人民军医出版社,2014.19-23. 被引量:1
  • 5Machado DE,Berardo PT,Landgraf RG,et al.A selective cyclooxygenase-2 inhibitor suppresses the growth of endometrionsis with an antiangiogenic effect in a rat mode[J].Fertil Steril,2010,93(8):2674-2679. 被引量:1
  • 6Pei L,Melmed S.Isolation and characterization of a pituitary tumortransforming gene(PTTG)[J].Mol Endocrinol,1997,11(4):433-441. 被引量:1
  • 7Horwitz GA,Miklovsky 1,Heaney AP,et al,Human pituitary tumortransforming gene(PTTG1)motif suppresses prolactin expression[J].Mol Endocrinol,2003,17(4):600-609. 被引量:1
  • 8Ishikawa H,Heaney AP,Yu R,et al.Human pituitary tumortransforming gene induces angiogenesis[J].Clin Endocrinol Metab,2001,86(2):867-874. 被引量:1
  • 9Kim DS,Frank lyn JA,Stratford AL,et al.Pituitary tumortransforming gene regulates multiple downstream angiogenic genes in thyroid cancer[J].Clin Endocrinol Metab,2006,91(3):1119-1128. 被引量:1
  • 10Sanchez AM, Vigano P, Quattrone F, et al. The WNT/β-cate- nin signaling pathway and expression of survival promoting genes in luteinized granulosa cells; endometriosis as a paradigm for a dysregulated apoptosis pathway [J]. Fertil Steril, 2014, 101(6) : 1688-1696. 被引量:1

引证文献15

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部